Earnings call transcript: ActiveOps posts strong H2 2026 growth as NRR hits 119%

ActiveOps reported FY revenue of GBP 45m (SaaS 85%) and ARR of GBP 41.5m (+46% YoY), with organic SaaS growth of 23% and organic net revenue retention at 119% (vs 108%–110% historical). Adjusted EBITDA rose 72% to GBP 4.3m and the adjusted EBITDA margin improved to 10% from 8%, alongside GBP 23.8m cash and zero debt. Despite shares trading nearly flat ($232.27, -0.1%), management reiterated ARR growth “in line with” current forecasts and expects integration savings to become clearer in H1.

Analysis

The market is treating this like a clean beat, but the more important signal is that the business is moving from “sell software” to “monetize workflow control in an AI-constrained world.” That should help partner-led distribution and reduce dependence on direct sales, but the payoff is lagged: the new sales hires and channel motion are more relevant to 6-18 month ARR durability than to the next print. The key second-order winner is not just the company itself; consultancies and BPOs that can bundle the product into transformation projects gain a higher-value pitch, while lower-value labor-arbitrage outsourcers face more scrutiny over where work should sit.

The main risk is that consensus is overweighting the AI narrative and underweighting pricing friction. A move to platform/variable pricing can preserve value, but it also telegraphs that seat-based expansion may be less durable if customers automate away activity; that is a subtle headwind to ARR quality even if revenue per customer holds. The real catalyst is the next half-year: if the incremental cost savings flow through and NRR stays above the prior 108-110% band, the stock deserves a higher multiple; if NRR normalizes while sales-cycle lag persists, the re-rating case fades quickly.

Contrarian view: the print is strong, but not obviously under-owned. The shares already sit in the upper half of the range, and the market may be waiting for proof that current expansion is repeatable after the one-off uplift from acquisition and price increases rolls off. On balance, this looks like a quality-compounder story, but the risk/reward is better on dips or on confirmation that partner-sourced ARR is accelerating rather than on chasing the release.

Key Decisions for Investors

• Tactically add to AOM only on weakness toward the lower end of its recent range; use the next half-year update as the catalyst. Upside is a higher multiple if H1 shows margin expansion and no NRR fade; thesis breaks if organic NRR drops back toward 110% or below.
• Do not chase the print outright; wait for evidence that the additional sales hires are converting into partner-sourced pipeline. If the company does not show measurable channel contribution by the next update, treat the current growth rate as already reflected in price.
• Pair trade: long IGV or WCLD versus short WNS or EXLS as a basket expression of software instrumentation outperforming labor-arbitrage/process-outsourcing models in an AI-automation cycle. Risk/reward works if the market starts rewarding recurring software quality over service-heavy revenue mixes.
• Set a thesis stop on AOM if management implies variable pricing is pressuring deal volume or if the next guide points to ARR growth below current market forecasts. That would signal the AI/automation narrative is not translating into monetization at the pace investors expect.